Vera Bradley Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Vera Bradley şirketinin toplam hissedar öz sermayesi $242.5M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $379.2M ve $136.7M dir. Vera Bradley 'in FAVÖK'ü $1.7M faiz karşılama oranı -0.9 dur. Şirketin $44.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	-0.9x
Nakit	US$44.15m
Eşitlik	US$242.53m
Toplam yükümlülükler	US$136.68m
Toplam varlıklar	US$379.21m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Vera Bradley Is Too Risky: 2Q25 Was Challenging, And Does Not Even Include Its Criticized Rebranding

Sep 17

The Consensus EPS Estimates For Vera Bradley, Inc. (NASDAQ:VRA) Just Fell Dramatically

Sep 16

Vera Bradley, Inc.'s (NASDAQ:VRA) Revenues Are Not Doing Enough For Some Investors

Sep 12

At US$4.60, Is It Time To Put Vera Bradley, Inc. (NASDAQ:VRA) On Your Watch List?

Aug 11

Vera Bradley: Don't Get Left Holding The Bag

Aug 09

Vera Bradley CEO Wallstrom to retire; firm identifies $25M annualized cost cuts

Jul 21

Vera Bradley: Packing The Bags Here

May 11

Should You Investigate Vera Bradley, Inc. (NASDAQ:VRA) At US$7.26?

Apr 06

Vera Bradley, Inc.'s (NASDAQ:VRA) Intrinsic Value Is Potentially 68% Above Its Share Price

Mar 16

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: VRA 'nin kısa vadeli varlıkları ( $223.5M ) kısa vadeli yükümlülüklerini ( $78.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: VRA şirketinin kısa vadeli varlıkları ( $223.5M ) uzun vadeli yükümlülüklerini ( $58.4M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: VRA borçsuzdur.

Borcun Azaltılması: VRA un 5 yıl önce borcu yoktu.

Borç Kapsamı: VRA un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: VRA şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

Vera Bradley Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Vera Bradley, Inc. Announces Appointment of Ian Bickley to the Board of Directors

Consensus revenue estimates fall by 12%

Vera Bradley Is Too Risky: 2Q25 Was Challenging, And Does Not Even Include Its Criticized Rebranding

The Consensus EPS Estimates For Vera Bradley, Inc. (NASDAQ:VRA) Just Fell Dramatically

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Vera Bradley, Inc.'s (NASDAQ:VRA) Revenues Are Not Doing Enough For Some Investors

Price target decreased by 21% to US$7.50

Vera Bradley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 1, 2025

Investor sentiment deteriorates as stock falls 16%

Vera Bradley, Inc. to Report Q2, 2025 Results on Sep 11, 2024

Vera Bradley, Inc. Unveils New, Elevated Product Line

Consensus EPS estimates fall by 55%

Vera Bradley: Project Restoration Promising, But Looking For Net Revenue Growth

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Vera Bradley, Inc.'s (NASDAQ:VRA) Shareholders Might Be Looking For Exit

Investor sentiment deteriorates as stock falls 20%

Vera Bradley: A Risky Turnaround Play

Vera Bradley, Inc. to Report Q1, 2025 Results on Jun 12, 2024

Vera Bradley, Inc., Annual General Meeting, May 30, 2024

Vera Bradley's (NASDAQ:VRA) Earnings Seem To Be Promising

Vera Bradley: Stitching Together An Opportunity

Vera Bradley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 1, 2025

Full year 2024 earnings: EPS misses analyst expectations

Vera Bradley, Inc. to Report Q4, 2024 Results on Mar 13, 2024

Less than half of directors are independent

Vera Bradley, Inc. Appoints Jessica Rodriguez to Board of Directors

Vera Bradley, Inc. Announces Bradley Weston to Join Board of Directors

Independent Director recently sold US$252k worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Vera Bradley, Inc. Updates Earnings Guidance for the Fiscal Year Ending February 3, 2024

Should You Investigate Vera Bradley, Inc. (NASDAQ:VRA) At US$8.12?

Vera Bradley, Inc. to Report Q3, 2024 Results on Dec 06, 2023

Now 21% undervalued

Now 21% undervalued

Price target increased by 14% to US$9.50

New major risk - Revenue and earnings growth

Vera Bradley, Inc. Provides Consolidated Earnings Guidance for the Year Ending February 3, 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Vera Bradley, Inc. to Report Q2, 2024 Results on Aug 30, 2023

Insufficient new directors

Vera Bradley, Inc. Provides Consolidated Revenue Guidance for the Fiscal Year 2023

New major risk - Revenue and earnings growth

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Vera Bradley, Inc. to Report Q4, 2023 Results on Mar 08, 2023

Vera Bradley, Inc. (NasdaqGS:VRA) entered into an Interest Purchase Agreement to acquire remaining 25% stake in Creative Genius, Inc. for $10 million.

Vera Bradley, Inc. (NasdaqGS:VRA) entered into an Interest Purchase Agreement to acquire remaining 25% stake in Creative Genius, Inc. for $10 million.

Vera Bradley, Inc. Announces Resignation of Nancy R. Twine to Board of Directors, Effective May 25, 2023

Now 20% undervalued

Vera Bradley, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Is Vera Bradley, Inc. (NASDAQ:VRA) Potentially Undervalued?

Price target decreased to US$7.17

Vera Bradley, Inc. to Report Q3, 2023 Results on Dec 07, 2022

Vera Bradley, Inc. Announces Executive Changes

Vera Bradley hires new CEO

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Now 26% undervalued after recent price drop

Vera Bradley, Inc. Updates Consolidated Earnings Guidance for the Fiscal 2023

Vera Bradley Q2 2023 Earnings Preview

At US$4.60, Is It Time To Put Vera Bradley, Inc. (NASDAQ:VRA) On Your Watch List?

Vera Bradley: Don't Get Left Holding The Bag

Vera Bradley, Inc. to Report Q2, 2023 Results on Aug 31, 2022

Vera Bradley, Inc. Announces Retirement of Robert Wallstrom, Chief Executive Officer

Vera Bradley CEO Wallstrom to retire; firm identifies $25M annualized cost cuts

Consensus forecasts updated

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Vera Bradley, Inc. Provides Consolidated Earnings Guidance for the Fiscal 2023

Vera Bradley, Inc. Releases A New Limited-Edition Pride Daisies Collection in Celebration of Pride Month

Investor sentiment improved over the past week

Vera Bradley: Packing The Bags Here

Vera Bradley, Inc. to Report Q1, 2023 Results on Jun 08, 2022

Vera Bradley, Inc. Names Lockie Andrews as Chief Growth Officer of Pura Vida Brand

Price target decreased to US$9.67